Last reviewed · How we verify

Ketamine with propofol

Henry M. Jackson Foundation for the Advancement of Military Medicine · FDA-approved active Small molecule

Ketamine with propofol is a Anesthetic combination Small molecule drug developed by Henry M. Jackson Foundation for the Advancement of Military Medicine. It is currently FDA-approved for Procedural sedation and anesthesia in emergency and military medical settings, Rapid sequence intubation.

Ketamine and propofol together provide rapid-onset anesthesia and analgesia by blocking NMDA receptors and enhancing GABAergic inhibition, respectively.

Ketamine and propofol together provide rapid-onset anesthesia and analgesia by blocking NMDA receptors and enhancing GABAergic inhibition, respectively. Used for Procedural sedation and anesthesia in emergency and military medical settings, Rapid sequence intubation.

At a glance

Generic nameKetamine with propofol
SponsorHenry M. Jackson Foundation for the Advancement of Military Medicine
Drug classAnesthetic combination
TargetNMDA receptor (ketamine); GABA-A receptor (propofol)
ModalitySmall molecule
Therapeutic areaAnesthesiology
PhaseFDA-approved

Mechanism of action

Ketamine is a non-competitive NMDA receptor antagonist that produces dissociative anesthesia and analgesia while maintaining airway reflexes. Propofol is a GABAergic agonist that enhances inhibitory neurotransmission, producing sedation and hypnosis. The combination leverages ketamine's analgesic and dissociative properties with propofol's rapid onset and offset for balanced anesthesia.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Ketamine with propofol

What is Ketamine with propofol?

Ketamine with propofol is a Anesthetic combination drug developed by Henry M. Jackson Foundation for the Advancement of Military Medicine, indicated for Procedural sedation and anesthesia in emergency and military medical settings, Rapid sequence intubation.

How does Ketamine with propofol work?

Ketamine and propofol together provide rapid-onset anesthesia and analgesia by blocking NMDA receptors and enhancing GABAergic inhibition, respectively.

What is Ketamine with propofol used for?

Ketamine with propofol is indicated for Procedural sedation and anesthesia in emergency and military medical settings, Rapid sequence intubation.

Who makes Ketamine with propofol?

Ketamine with propofol is developed and marketed by Henry M. Jackson Foundation for the Advancement of Military Medicine (see full Henry M. Jackson Foundation for the Advancement of Military Medicine pipeline at /company/henry-m-jackson-foundation-for-the-advancement-of-military-medicine).

What drug class is Ketamine with propofol in?

Ketamine with propofol belongs to the Anesthetic combination class. See all Anesthetic combination drugs at /class/anesthetic-combination.

What development phase is Ketamine with propofol in?

Ketamine with propofol is FDA-approved (marketed).

What are the side effects of Ketamine with propofol?

Common side effects of Ketamine with propofol include Hypotension, Respiratory depression, Emergence reactions (ketamine-related), Bradycardia, Apnea.

What does Ketamine with propofol target?

Ketamine with propofol targets NMDA receptor (ketamine); GABA-A receptor (propofol) and is a Anesthetic combination.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing